JUNS (Jupiter Neurosciences, Inc. Common Stock) Stock Analysis - Politician Trades

Jupiter Neurosciences, Inc. Common Stock (JUNS) is a publicly traded Healthcare sector company. As of May 20, 2026, JUNS trades at $0.35 with a market cap of $12.06M and a P/E ratio of -1.38. JUNS moved +7.81% today. Year to date, JUNS is -68.32%; over the trailing twelve months it is -43.16%. Its 52-week range spans $0.31 to $19.51. Rallies surfaces JUNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded JUNS stock?

Rallies tracks politician and congressional stock disclosures for JUNS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

JUNS Key Metrics

Key financial metrics for JUNS
MetricValue
Price$0.35
Market Cap$12.06M
P/E Ratio-1.38
EPS$-0.25
Dividend Yield0.00%
52-Week High$19.51
52-Week Low$0.31
Volume194.68M
Avg Volume0
Revenue (TTM)$21.80K
Net Income$-8.64M
Gross Margin0.00%

Latest JUNS News

Recent JUNS Insider Trades

  • Silva Alison D. bought 250 (~$256.575) on Jul 1, 2025.
  • Silva Alison D. bought 250 (~$257.175) on Jul 1, 2025.
  • Silva Alison D. bought 250 (~$258.5) on Jul 1, 2025.

JUNS Analyst Consensus

JUNS analyst coverage data. Average price target: $0.00.

Common questions about JUNS

Which politicians traded JUNS stock?
Rallies tracks politician and congressional stock disclosures for JUNS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in JUNS?
Yes. Rallies tracks politician and congressional stock disclosures for JUNS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is JUNS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JUNS. It does not provide personalized investment advice.
JUNS

JUNS